PATENT CLAIM ANALYSIS

Application Number: 16324365
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["435", "006140"]

Abstract:
The present technology relates to methods for excluding Lynch syndrome as a possible diagnosis in patients suffering from colorectal cancers or endometrial cancers. These methods are based on detecting the methylation status of the MLH1 promoter ‘C’ region in colorectal and endometrial cancer patients using an improved and highly sensitive methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) assay.

Claim (Index 14):
The method of any one of  claims 1 - 13 , wherein the sample is a formalin fixed paraffin-embedded tissue sample.

Metadata:
- Claim Count in Document: 58.0
- Percentile: 99.0
- Lexical Diversity: 1.16667
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15300399', '10971339', '12476981', '11518353', '14775876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6155120356138906
- 35 USC 102 Novelty (BERT): 0.5307504223061733
- Combined Prediction Score: 0.6070358742831189
- Mean Citation Score: 321.436012
- Max Citation Score: 329.37662
- Similarity Product: 199.313520033952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test